Literature DB >> 17994425

Interleukin (IL)-12, IL-2, interferon-gamma gene polymorphisms in subacute sclerosing panencephalitis patients.

Vuslat Yilmaz1, Veysi Demirbilek, Candan Gürses, Sibel P Yentür, Serap Uysal, Zuhal Yapici, Gülden Yilmaz, Aaron Muncey, Ozlem Cokar, Emel Onal, Aysen Gökyiğit, Güher Saruhan-Direskeneli.   

Abstract

Mutated measles virus variants have been claimed as the causing agent for subacute sclerosing panencephalitis (SSPE) developing several years after the recovery from measles infection. However, immune dysfunction may be considered related to a genetic susceptibility to this rare disease. Interleukin (IL)-2 -330 (rs2069 762) and +160 (rs2069 763), IL-12 p40 3' UTR (rs3213113), and interferon (IFN)-gamma +874 (rs2430561) polymorphisms are screened by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) and PCR-sequence-specific priming (SSP) methods in 87 SSPE patients and 106 healthy controls (HCs) as candidate genes of susceptibility. The distribution of the IL12B genotypes (rs3213113) showed a trend for a significant difference (P = .053). The frequency of IL12B C allele (P = .04, OR: 1.6) and CC genotype (P = .03, OR: 3.2) were both higher in SSPE patients than in HC. The IL2 -330 genotypes revealed lower frequencies of GG genotype (P = .03, OR: 0.4) as well as G allele (P = .02, OR: 0.6) in SSPE. IL2 -330+160 TG haplotype was more frequent in patients (P = .005, OR: 1.8), whereas GG haplotype was less frequent, compared to controls (P = .02, OR: 0.6). IFNG +874 polymorphism revealed no difference. These findings implicate possible effects of genetic polymorphisms in the susceptibility to SSPE, which need to be confirmed in other populations.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17994425     DOI: 10.1080/13550280701455383

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  35 in total

1.  A TaqI polymorphism in the 3'UTR of the IL-12 p40 gene correlates with increased IL-12 secretion.

Authors:  D Seegers; A Zwiers; W Strober; A S Peña; G Bouma
Journal:  Genes Immun       Date:  2002-11       Impact factor: 2.676

2.  Measles virus-specific T helper 1/T helper 2-cytokine production in subacute sclerosing panencephalitis.

Authors:  T Hara; S Yamashita; H Aiba; K Nihei; N Koide; R A Good; K Takeshita
Journal:  J Neurovirol       Date:  2000-04       Impact factor: 2.643

Review 3.  Measles: immunosuppression, interleukin-12, and complement receptors.

Authors:  C L Karp
Journal:  Immunol Rev       Date:  1999-04       Impact factor: 12.988

Review 4.  Neuroprogressive disease of post-infectious origin: a review of a resurging subacute sclerosing panencephalitis (SSPE).

Authors:  P R Dyken
Journal:  Ment Retard Dev Disabil Res Rev       Date:  2001

5.  Subacute sclerosing panencephalitis.

Authors:  M C Graves
Journal:  Neurol Clin       Date:  1984-05       Impact factor: 3.806

6.  Natural measles causes prolonged suppression of interleukin-12 production.

Authors:  S F Atabani; A A Byrnes; A Jaye; I M Kidd; A F Magnusen; H Whittle; C L Karp
Journal:  J Infect Dis       Date:  2001-05-30       Impact factor: 5.226

7.  Subacute sclerosing panencephalitis: more cases of this fatal disease are prevented by measles immunization than was previously recognized.

Authors:  William J Bellini; Jennifer S Rota; Luis E Lowe; Russell S Katz; Paul R Dyken; Sherif R Zaki; Wun-Ju Shieh; Paul A Rota
Journal:  J Infect Dis       Date:  2005-10-12       Impact factor: 5.226

8.  No evidence for association between the polymorphism in the 3' untranslated region of interleukin-12B and human susceptibility to tuberculosis.

Authors:  Xin Ma; Robert A Reich; Omar Gonzalez; Xi Pan; Amanda K Fothergill; Jeffery R Starke; Larry D Teeter; James M Musser; Edward A Graviss
Journal:  J Infect Dis       Date:  2003-09-26       Impact factor: 5.226

9.  SSPE-BIKEN: a naturally arising hemagglutination-defective mutant of measles virus.

Authors:  A M Breschkin; E M Morgan; J McKimm; F Rapp
Journal:  J Med Virol       Date:  1979       Impact factor: 2.327

10.  Associations between IL12B polymorphisms and tuberculosis in the Hong Kong Chinese population.

Authors:  Hoi W Tso; Yu Lung Lau; Cheuk M Tam; Hing S Wong; Alan K S Chiang
Journal:  J Infect Dis       Date:  2004-07-30       Impact factor: 5.226

View more
  8 in total

1.  Interleukin-12 (-1188) A/C and interferon-γ (+874) A/T gene polymorphisms in subacute sclerosing panencephalitis patients.

Authors:  Nihal Olgac Dundar; Pinar Gencpinar; Nilgun Sallakci; Ozgur Duman; Senay Haspolat; Banu Anlar; Olcay Yegin
Journal:  J Neurovirol       Date:  2016-04-21       Impact factor: 2.643

Review 2.  Influence of interleukin polymorphisms on development of gastric cancer and peptic ulcer.

Authors:  Mitsushige Sugimoto; Yoshio Yamaoka; Takahisa Furuta
Journal:  World J Gastroenterol       Date:  2010-03-14       Impact factor: 5.742

Review 3.  The genetic basis for interindividual immune response variation to measles vaccine: new understanding and new vaccine approaches.

Authors:  Iana H Haralambieva; Inna G Ovsyannikova; V Shane Pankratz; Richard B Kennedy; Robert M Jacobson; Gregory A Poland
Journal:  Expert Rev Vaccines       Date:  2013-01       Impact factor: 5.217

4.  Characteristics of viruses derived from nude mice with persistent measles virus infection.

Authors:  Yusaku Abe; Koichi Hashimoto; Masahiro Watanabe; Shinichiro Ohara; Masatoki Sato; Yukihiko Kawasaki; Yuko Hashimoto; Mitsuaki Hosoya
Journal:  J Virol       Date:  2013-01-23       Impact factor: 5.103

5.  IFN-γ (+874) and not TNF-α (-308) is associated with HBV-HCC risk in India.

Authors:  Roli Saxena; Yogesh Kumar Chawla; Indu Verma; Jyotdeep Kaur
Journal:  Mol Cell Biochem       Date:  2013-10-08       Impact factor: 3.396

Review 6.  Measles virus infection of the CNS: human disease, animal models, and approaches to therapy.

Authors:  Dajana Reuter; Jürgen Schneider-Schaulies
Journal:  Med Microbiol Immunol       Date:  2010-08       Impact factor: 4.148

7.  Subacute sclerosing panencephalitis in papua new guinean children: the cost of continuing inadequate measles vaccine coverage.

Authors:  Laurens Manning; Moses Laman; Henry Edoni; Ivo Mueller; Harin A Karunajeewa; David Smith; Ilomo Hwaiwhanje; Peter M Siba; Timothy M E Davis
Journal:  PLoS Negl Trop Dis       Date:  2011-01-04

Review 8.  Advances in Antiviral Therapy for Subacute Sclerosing Panencephalitis.

Authors:  Koichi Hashimoto; Mitsuaki Hosoya
Journal:  Molecules       Date:  2021-01-15       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.